News

The difficulty of mining Bitcoin (CRYPTO: $BTC) continues to decline as the price of the largest digital asset rema...

EIX Q2 earnings surge 58.8% and beat estimates by 51%, while revenues decline and miss expectations.

The stock of Coinbase Global (NASDAQ: $COIN) is down 6% after the cryptocurrency platform reported disappointing fi...

Circle's NYDFS trust charter complements its earlier OCC approval, creating a two-tier structure where Circle New York Trust issues USDC while Circle National Trust safeguards the reserves backing the stablecoin.

The iPhone maker reported its third quarter earnings on Thursday, beating analysts' expectations on the top and bottom lines on strong iPhone sales, but shares fell after Services and Greater China sales came up short.

Apple just posted record quarterly results and watched nearly $350 billion in market value vanish overnight. The culprit is a supply crisis Tim Cook once called a hundred-year flood, and it may define the final chapter of his tenure.

Novo Nordisk shares dropped after the Danish drugmaker said an experimental medicine didn't reduce risk of major adverse cardiovascular events in a late-stage trial. The company's Denmark-listed stock was down nearly 10%, while its American depositary receipts fell about 9% in premarket trading in New York.

The selloff in Reddit shares came as investors looked past the earnings beat and focused on slowing U.S. user growth and management's commentary on its relationship with Google.

Musk Rejects Tesla China Exit Claims as SpaceX Merger Buzz Grows

Investing.com -- AbbVie Inc. (NYSE: ABBV) reported second-quarter earnings before the open on Friday, missing profit expectations, although revenue beat the consensus estimate.

Investing.com -- Novo Nordisk (NYSE: NVO) shares dropped 10% Friday after the drugmaker revealed its experimental drug, ziltivekimab, failed to cut cardiovascular risk in a late-stage clinical trial.

The stock was down 9.5% after the company’s experimental medicine ziltivekimab didn’t achieve the expected risk reduction for major cardiovascular events.

LyondellBasell (LYB) delivered earnings and revenue surprises of +20.79% and +3.11%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Pepper Money will act as the loan management partner for the portfolio.

Exxon (XOM) delivered earnings and revenue surprises of -4.35% and +21.10%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Cameco (CCJ) delivered earnings and revenue surprises of -50.00% and +10.04%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Colgate-Palmolive recorded higher sales in the second quarter, despite a choppy consumer environment.

Gebbia liquidated his entire indirect position under a pre-arranged trading plan, executing at $150.92 per share versus a $153.11 market close.

Several brokerages, including Barclays, Goldman Sachs, BTIG, and Clear Street, lowered their price targets on COIN stock following the earnings report.

Adjusted second-quarter earnings of $3.52 a share came in 2 cents below analyst forecasts, with scheduled maintenance limiting fuel-making profits

Investing.com -- ExxonMobil shares slid around 2% in premarket trading Friday after the U.S. energy major reported earnings for the second quarter that missed average analyst forecasts.

Rocket Lab signed a new multi-launch deal with Japanese Earth imaging company iQPS for three dedicated Electron missions. The agreement expands an existing launch partnership and lifts the total planned missions between the companies to 18. This latest contract focuses on deploying iQPS satellites for its synthetic aperture radar constellation. Rocket Lab, listed as NasdaqGS:RKLB, continues to build out its commercial launch backlog at a time when its stock has been volatile. The share...

Wall Street was feeling less anxious to end what has been a volatile month for markets. The Cboe Volatility Index, or Vix, fell 1.8% to 16.8. Any reading above 20 tends to indicate relatively high volatility.

JPMorgan warns that fading CLARITY Act odds are a setback for crypto markets since further delays give traditional finance infrastructure a bigger head start over public crypto networks. JPMorgan’s Warning: This Is Not Just About a Delayed Vote JPMorgan analysts...

Analysts at Morningstar said in a recent note that Apple's outlook points to mounting pressure from AI-driven memory inflation, tight chip supply and foreign exchange headwinds.

The supplier to major automakers, including BMW, Volkswagen and Ford slashed its medium-term sales expectations against a darkening backdrop for the industry.

The project, which is largely tied to the innovative medicine segment, will see the company exit certain facilities and incur costs of up to $750 million.

Micron stock was building on huge gains from the previous day as Apple and Amazon confirmed there’s no end in sight to the memory-chip shortage.

For Apple shareholders, here’s a way to get paid a meaningful income now, which you keep no matter what, in exchange for agreeing to sell at a price above today's if the stock keeps climbing.

No earnings beat may be sufficient to prop up Palantir's shares this earnings season.